Meritage Group NEPH trades
Nathaniel Simons
Nathaniel Simons Nephros Inc stake
total: 303
Trades details
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Nathaniel Simons holds 173,407 Nephros Inc (NEPH) shares with a market value of roughly $643.34K accounting for 0.02% of the overall portfolio. To date, the estimated cost basis is nearly $3.71 for "buy" trades. Meritage Group first purchased NEPH in 2026 Q3, initially acquiring 173,407 shares.
When did Nathaniel Simons buy Nephros Inc (NEPH)?
Nathaniel Simons first invested in Nephros Inc (NEPH) in 2026 Q3 at the reported quarter-end price of $3.71 per share.
What's the cost basis of Meritage Group's NEPH stake?
The estimated cost basis for Nephros Inc (NEPH) stake is around $3.71 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $3.71
Nathaniel Simons's historical trades in Nephros Inc
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.02%
|
173,407
|
$3.71
|
$643,340
|
new
|
+0.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.